HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brush border myosin Ia has tumor suppressor activity in the intestine.

Abstract
The loss of the epithelial architecture and cell polarity/differentiation is known to be important during the tumorigenic process. Here we demonstrate that the brush border protein Myosin Ia (MYO1A) is important for polarization and differentiation of colon cancer cells and is frequently inactivated in colorectal tumors by genetic and epigenetic mechanisms. MYO1A frame-shift mutations were observed in 32% (37 of 116) of the colorectal tumors with microsatellite instability analyzed, and evidence of promoter methylation was observed in a significant proportion of colon cancer cell lines and primary colorectal tumors. The loss of polarization/differentiation resulting from MYO1A inactivation is associated with higher tumor growth in soft agar and in a xenograft model. In addition, the progression of genetically and carcinogen-initiated intestinal tumors was significantly accelerated in Myo1a knockout mice compared with Myo1a wild-type animals. Moreover, MYO1A tumor expression was found to be an independent prognostic factor for colorectal cancer patients. Patients with low MYO1A tumor protein levels had significantly shorter disease-free and overall survival compared with patients with high tumoral MYO1A (logrank test P = 0.004 and P = 0.009, respectively). The median time-to-disease recurrence in patients with low MYO1A was 1 y, compared with >9 y in the group of patients with high MYO1A. These results identify MYO1A as a unique tumor-suppressor gene in colorectal cancer and demonstrate that the loss of structural brush border proteins involved in cell polarity are important for tumor development.
AuthorsRocco Mazzolini, Higinio Dopeso, Silvia Mateo-Lozano, Wakam Chang, Paulo Rodrigues, Sarah Bazzocco, Hafid Alazzouzi, Stefania Landolfi, Javier Hernández-Losa, Elena Andretta, Pia Alhopuro, Eloy Espín, Manel Armengol, Josep Tabernero, Santiago Ramón y Cajal, Matthias Kloor, Johannes Gebert, John M Mariadason, Simo Schwartz Jr, Lauri A Aaltonen, Mark S Mooseker, Diego Arango
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 109 Issue 5 Pg. 1530-5 (Jan 31 2012) ISSN: 1091-6490 [Electronic] United States
PMID22307608 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Myosin Type I
Topics
  • Cell Line, Tumor
  • Colorectal Neoplasms (genetics, metabolism, pathology)
  • DNA Methylation
  • Genes, Tumor Suppressor
  • Humans
  • Intestinal Mucosa (metabolism)
  • Microvilli (metabolism)
  • Mutation
  • Myosin Type I (genetics, physiology)
  • Promoter Regions, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: